Table 2.
Infusion-related adverse effect | Timing |
Intervention N reactions |
Withdrawal N patients |
||
---|---|---|---|---|---|
During |
After |
Unknown |
|||
N patients I N reactions | |||||
Moderate | |||||
Delayed hypersensitivity | NA | 9 I 12 | NA | 3 | 1 |
Hypotension | 2 I 2a | 0 I 0 | 0 I 0 | 1 | 0 |
Nausea | 1 I 1 | 0 I 0 | 0 I 0 | 1 | 0 |
Various | 4 I 6 | 2 I 2a | 0 I 0 | 5 | 0 |
Vasovagal reactions | 8 I 8 | NA | NA | 9 | 0 |
Mild | |||||
Diarrhoea | 0 I 0 | 1 I 1 | 1 I 1 | 0 | 0 |
Dizziness | 3 I 3a | 4 I 4 | 1 I 1 | 0 | 0 |
Dyspnoea | 0 I 0 | 2 I 2 | 0 I 0 | 0 | 0 |
Flushing | 1 I 1 | 0 I 0 | 0 I 0 | 1 | 0 |
Headache | 1 I 1 | 4 I 4 | 5 I 5a | 2 | 0 |
Nausea | 1 I 1a | 2 I 2 | 1 I 1 | 1 | 0 |
Palpitations | 0 I 0 | 4 I 5a | 3 I 3 | 0 | 0 |
Skin reactions | 1 I 1 | 2 I 2 | 2 I 2 | 0 | 0 |
Thoracic pain | 1 I 1 | 0 I 0 | 0 I 0 | 0 | 0 |
Vomiting | 0 I 0 | 1 I 1 | 1 I 1 | 0 | 0 |
These numbers include patients who experienced symptoms by every infusion.